Interesting...
Novartis applied for a patent to make the swine flu vaccine in 2005
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220090047353%22.PGNR.&OS=DN/20090047353&RS=DN/20090047353
Baxter applied for a patent to make the swine flu vaccine in 2008
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220090060950%22.PGNR.&OS=DN/20090060950&RS=DN/20090060950
Patents protecting the proprietary flu vaccine must be applied for and secured before the pandemic virus is released in order to minimize the competition and maximize the profit potentials. In a biological attack of this nature, timing is extremely critical. Good job Novartis and Baxter!
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment